Document Detail


Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells.
MedLine Citation:
PMID:  23340407     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A method for stimulating the differentiation of human pluripotent stem cells into kidney lineages remains to be developed. Most cells in kidney are derived from an embryonic germ layer known as intermediate mesoderm. Here we show the establishment of an efficient system of homologous recombination in human pluripotent stem cells by means of bacterial artificial chromosome-based vectors and single-nucleotide polymorphism array-based detection. This system allowed us to generate human-induced pluripotent stem cell lines containing green fluorescence protein knocked into OSR1, a specific intermediate mesoderm marker. We have also established a robust induction protocol for intermediate mesoderm, which produces up to 90% OSR1(+) cells. These human intermediate mesoderm cells can differentiate into multiple cell types of intermediate mesoderm-derived organs in vitro and in vivo, thereby supplying a useful system to elucidate the mechanisms of intermediate mesoderm development and potentially providing a cell source for regenerative therapies of the kidney.
Authors:
Shin-Ichi Mae; Akemi Shono; Fumihiko Shiota; Tetsuhiko Yasuno; Masatoshi Kajiwara; Nanaka Gotoda-Nishimura; Sayaka Arai; Aiko Sato-Otubo; Taro Toyoda; Kazutoshi Takahashi; Naoki Nakayama; Chad A Cowan; Takashi Aoi; Seishi Ogawa; Andrew P McMahon; Shinya Yamanaka; Kenji Osafune
Related Documents :
23211037 - Disrupting bcr-abl in combination with secondary leukemia-specific pathways in cml cell...
23064187 - Cd4(+) th1 cells are effectors in lupus nephritis-but what are their targets?
23167967 - Dendritic cell subsets in mycobacterial infection: control of bacterial growth and t c...
23887957 - Osteogenic differentiation of human adipose-derived stem cells can be accelerated by co...
11244047 - Ctla-4-mediated inhibition in regulation of t cell responses: mechanisms and manipulati...
21659957 - Baby steps: a giant leap for cell therapy in neonatal brain injury.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Nature communications     Volume:  4     ISSN:  2041-1723     ISO Abbreviation:  Nat Commun     Publication Date:  2013  
Date Detail:
Created Date:  2013-01-23     Completed Date:  2013-06-20     Revised Date:  2014-06-26    
Medline Journal Info:
Nlm Unique ID:  101528555     Medline TA:  Nat Commun     Country:  England    
Other Details:
Languages:  eng     Pagination:  1367     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Differentiation
Cell Line
Embryoid Bodies / cytology
Embryonic Stem Cells / cytology
Flow Cytometry
Gene Dosage / genetics
Gene Expression Regulation, Developmental
Gene Knock-In Techniques
Gene Targeting
Genetic Loci / genetics
Green Fluorescent Proteins / metabolism
Humans
Induced Pluripotent Stem Cells / cytology*,  metabolism
Kidney / cytology,  embryology*,  metabolism
Mesoderm / cytology*,  embryology*
Mice
Polymorphism, Single Nucleotide / genetics
Protein-Serine-Threonine Kinases / metabolism
Time Factors
Grant Support
ID/Acronym/Agency:
DK054364/DK/NIDDK NIH HHS; R37 DK054364/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
147336-22-9/Green Fluorescent Proteins; EC 2.7.11.1/OSR1 kinase, mouse; EC 2.7.11.1/Protein-Serine-Threonine Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells.
Next Document:  The random mass Dirac model and long-range correlations on an integrated optical platform.